Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Romania

Romania Articles

Industry

BMI view: The sale of Tavanic (levofloxacin) in Romania and South Africa demonstrates how Daiichi Sankyo and Ranbaxy's partnership is creating positive operational synergies for both... 2010-07-27


Industry

BMI View: Romania's new centrist government is looking to push through major reform to the healthcare system, including the introduction of patient fees and decentralisation of the... 2010-05-07


Industry

BMI View: Romania is forecast to be the fastest expanding EU pharmaceutical market in 2010, albeit at a lower rate than in 2009. This view has been supported by confirmed Q110 medicine... 2010-05-06


More ARTICLES

Industry

BMI's view that the full privatisation of pharmaceutical company Antibiotice Iasi is extremely unlikely in the short term[1] has been given further credence following Romanian Prime... 2010-03-25


BMI has introduced greater clarity to its core views for the Pharmaceuticals & Healthcare. Short-term core views concern the period through to the end of the 2011-2013 patent cliff,... 2010-03-15


Industry

BMI calculates that total health expenditure in Romania was RON31.2bn (US$11.3bn) in 2009, a 6.8% year-on-year increase. This equates to 6.7% of GDP, below the regional average of... 2010-02-12


Industry

BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected... 2010-01-05


Industry

A&D Pharma Holdings, the owner of Romania's leading pharmaceutical wholesale, sales and marketing services and retail business, has confirmed the acquisition of privately held... 2009-12-29

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries